Stock Track | Tempus AI Soars 5.11% in Pre-Market After Ark Invest Purchase and Strong Q1 Results

Stock Track
May 28

Tempus AI's stock soared 5.11% in pre-market trading on Thursday.

The surge follows news that Cathie Wood-led Ark Invest purchased 25,910 shares of the company, amounting to an investment of approximately $1.2 million, through its ARK Genomic Revolution ETF on Wednesday.

Investor sentiment was further bolstered by Tempus AI's strong first-quarter financial results, which showed revenue of $348.12 million, up 36.1% year-over-year and slightly above analyst expectations. The company also reported a narrower-than-expected loss and raised its full-year 2026 revenue outlook to between $1.59 billion and $1.60 billion, projecting adjusted EBITDA of approximately $65 million as demand for its AI-powered diagnostics platform continues to expand.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10